49.05
price up icon0.08%   0.04
after-market 시간 외 거래: 49.40 0.35 +0.71%
loading
전일 마감가:
$49.01
열려 있는:
$49
하루 거래량:
932.94K
Relative Volume:
0.31
시가총액:
$7.16B
수익:
$10.73M
순이익/손실:
$-455.74M
주가수익비율:
-13.79
EPS:
-3.5569
순현금흐름:
$-502.70M
1주 성능:
+1.91%
1개월 성능:
+19.46%
6개월 성능:
+71.98%
1년 성능:
+5.01%
1일 변동 폭
Value
$48.25
$49.45
1주일 범위
Value
$46.09
$51.79
52주 변동 폭
Value
$21.51
$56.00

어비디티 바이오사이언스 Stock (RNA) Company Profile

Name
명칭
Avidity Biosciences Inc
Name
전화
858-401-7900
Name
주소
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
직원
391
Name
트위터
Name
다음 수익 날짜
2024-12-07
Name
최신 SEC 제출 서류
Name
RNA's Discussions on Twitter

RNA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RNA
Avidity Biosciences Inc
49.05 7.15B 10.73M -455.74M -502.70M -3.5569
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

어비디티 바이오사이언스 Stock (RNA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-17 개시 Roth Capital Buy
2025-07-10 재개 Goldman Buy
2025-06-24 개시 Bernstein Outperform
2025-06-17 개시 Wolfe Research Outperform
2025-06-11 개시 Raymond James Strong Buy
2025-03-13 개시 Citigroup Buy
2025-03-12 개시 BMO Capital Markets Outperform
2025-03-07 개시 Scotiabank Sector Outperform
2024-12-20 개시 H.C. Wainwright Buy
2024-11-26 개시 RBC Capital Mkts Outperform
2024-09-24 개시 Goldman Buy
2024-08-28 개시 Barclays Overweight
2024-05-03 개시 BofA Securities Buy
2024-03-14 개시 Cantor Fitzgerald Overweight
2023-05-22 업그레이드 Evercore ISI In-line → Outperform
2023-03-31 다운그레이드 Evercore ISI Outperform → In-line
2022-07-20 개시 Chardan Capital Markets Buy
2022-07-12 개시 Raymond James Strong Buy
2021-09-07 개시 Evercore ISI Outperform
2021-06-17 개시 Needham Buy
2021-04-26 재개 Credit Suisse Outperform
2020-07-07 개시 Cowen Outperform
2020-07-07 개시 Credit Suisse Outperform
2020-07-07 개시 SVB Leerink Outperform
2020-07-07 개시 Wells Fargo Overweight
모두보기

어비디티 바이오사이언스 주식(RNA)의 최신 뉴스

pulisher
Oct 21, 2025

What momentum shifts mean for Avidity Biosciences Inc.Jobs Report & Daily Entry Point Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Ranking Avidity Biosciences Inc. among high performing stocks via toolsDip Buying & Fast Gain Stock Tips - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Avidity Biosciences Inc. stock daily chart insightsMarket Volume Report & Technical Analysis for Trade Confirmation - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Avidity Biosciences Inc. stock beat market expectations this quarterDividend Hike & Risk Controlled Daily Trade Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

How Avidity Biosciences Inc. stock compares to growth peersTrade Ideas & Verified Technical Trade Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Avidity Biosciences, Inc. (RNA) Investor Outlook: Strong Buy Ratings Signal 42% Upside Potential - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 19, 2025

Using R and stats models for Avidity Biosciences Inc. forecastingDollar Strength & Growth Focused Investment Plans - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Avidity Biosciences Inc. stock trendline breakdownJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Is Avidity Biosciences Inc. stock a top pick in earnings seasonShare Buyback & Low Drawdown Investment Strategies - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Aug Closing: Can Avidity Biosciences Inc. stock hit record highs again - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Aug EndMonth: Can Avidity Biosciences Inc. stock hit record highs againPortfolio Update Report & Reliable Price Action Trade Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Avidity Biosciences Inc. stock a defensive play in 2025Market Activity Report & High Accuracy Investment Entry Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Avidity Biosciences Insider Sold Shares Worth $1,003,058, According to a Recent SEC Filing - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Avidity Biosciences Executive Sells 20,000 Shares - TradingView

Oct 17, 2025
pulisher
Oct 17, 2025

Avidity Biosciences Form 4: 20,000 options exercised at $22.34 - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

How Avidity Biosciences Inc. stock performs in weak economyPortfolio Update Report & Low Drawdown Investment Strategies - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Facioscapulohumeral Muscular Dystrophy Market Analysis Report 2025-2035: Innovations from Leading Players Such as Avidity Biosciences, F. Hoffman-La Roche, Epicrispr, and Fulcrum Fuel ExpansionResearchAndMarkets.com - The AI Journal

Oct 17, 2025
pulisher
Oct 17, 2025

Will FDA Feedback and Del-Zota BLA Timeline Shift Redefine Avidity Biosciences' (RNA) Late-Stage Pipeline? - Yahoo Finance

Oct 17, 2025
pulisher
Oct 16, 2025

Will a bounce in Avidity Biosciences Inc. offer an exitTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Is Avidity Biosciences Inc a good long term investmentRisk Management Strategies & Tap Into the Fastest-Growing Companies - earlytimes.in

Oct 16, 2025
pulisher
Oct 16, 2025

Avidity reports positive pre-BLA meeting on Duchenne muscular dystrophy asset del-zota - MSN

Oct 16, 2025
pulisher
Oct 16, 2025

Oct 21 panel: Avidity Biosciences to speak at Chardan Conference; webcast available 11:00 PT - Stock Titan

Oct 16, 2025
pulisher
Oct 16, 2025

Avidity Biosciences to Participate in Upcoming Investor Conference - Sahm

Oct 16, 2025
pulisher
Oct 15, 2025

Sector ETF performance correlation with Avidity Biosciences Inc.Trade Ideas & Weekly Top Gainers Trade List - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Forecasting Avidity Biosciences Inc. price range with options data2025 EndofYear Setup & High Return Stock Watch Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Avidity Biosciences Inc (RNA) Technical Analysis - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

What Makes Avidity Biosciences (RNA) an Investment Choice? - MSN

Oct 14, 2025
pulisher
Oct 14, 2025

[8-K] – Avidity Biosciences, Inc. (RNA) (CIK 0001599901) | RNA SEC FilingForm 8-K - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

Avidity Biosciences Delays Biologics License Application - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

Avidity Biosciences Updates BLA Submission Timeline for Del-Zota - TradingView

Oct 14, 2025
pulisher
Oct 14, 2025

Avidity updates FDA filing plan; del-zota BLA now expected Q1 2026 - Stock Titan

Oct 14, 2025
pulisher
Oct 13, 2025

Avidity Biosciences delays DMD drug submission to Q1 2026 By Investing.com - Investing.com Nigeria

Oct 13, 2025
pulisher
Oct 13, 2025

Avidity rises on plans to submit muscle wasting drug application to US FDA - TradingView

Oct 13, 2025
pulisher
Oct 13, 2025

Avidity Biosciences Completes FDA Pre-BLA Meeting for Del-Zota, Targets 2026 Submission - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026 - Investing News Network

Oct 13, 2025
pulisher
Oct 13, 2025

Avidity Biosciences delays DMD drug submission to Q1 2026 - Investing.com India

Oct 13, 2025
pulisher
Oct 13, 2025

Avidity Biosciences announces positive pre-BLA meeting with US FDA for del-zota in DMD44 - MarketScreener

Oct 13, 2025

어비디티 바이오사이언스 (RNA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
자본화:     |  볼륨(24시간):